Day One - ET (Eastern Time, GMT-05:00)
South Florida is solidifying its position as a national healthcare and life sciences hub. With its strategic location, growing infrastructure, and influx of investment, the city is becoming a magnet for innovation and collaboration. This panel will delve into the key drivers behind South Florida’s rise, the opportunities it presents for investors and innovators, and the challenges that lie ahead in sustaining this momentum
- South Florida’s strategic role in global healthcare
- Insights into the capital influx, public-private partnerships, and infrastructure developments that are fuelling South Florida’s transformation
- The role of South Florida’s universities, research institutions, and healthcare organizations in fostering cutting-edge research and a skilled workforce
- Sustaining momentum and strategies to ensure South Florida's long-term success in the life sciences sector
- Raquel Cabo - Founder, Miami Biotech Collective
- Greg Horowitz - Partner, HealthConnect Village
- Courtney Miller - CEO & Co-Founder, Myosin Therapeutics
- Jackson Streeter - Director, UF Innovate Ventures, University of Florida
- Anthony Japour - CEO, iTolerance
- Ben Comer - Chief Editor, Life Science Leader
Every groundbreaking biotech innovation starts with a bold idea—and the people who dare to bring it to life. This panel takes you on a journey into the heart of early-stage biotech, where vision meets opportunity. Hear stories of how startups navigate the maze of funding and entrepreneurial support to turn dreams into reality. Explore the art of building multidisciplinary teams that push boundaries and the qualities of leaders who inspire innovation. Together, we’ll uncover strategies to cultivate and empower the next generation of biotech entrepreneurs, ensuring the future of the industry is as bright as the discoveries it promises
- Exploring what funding opportunities and entrepreneurial support is available for early-stage biotech startups
- Insights into building multidisciplinary teams and biotech companies
- Defining the qualities of effective leaders and their role in driving innovation
- Discussing strategies to attract, develop, and retain the next generation of biotech entrepreneurs and leaders
- Exploring academic and non-academic routes to successful ventures
- Avni Bhalgat - Managing Director, Nucleate Florida
- Ismael Voltaire - Co-Founder & CEO, PRODIA Technologies
- Johan Wikström - CEO & Co-Founder, Tolka AI Therapeutics
- William Silverman - Executive Director, Coulter Program & New Ventures, University of Miami, Miller School of Medicine
